Cergentis
Menu

EHA Congress - Amsterdam, NL

13 June 2019 - 16 June 2019Conferences

Join Harma Feitsma and discover TLA for targeted NGS of all relevant mutations and gene fusions and why that is relevant for disease prognosis, therapy decisions and MRD testing for leukemia and lymphoma patients. Check out our website on what we have to offer and feel free to reach out to schedule a short meeting.

Overview
© 2012-2020 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.